Kisqali (600 MG Dose) and Onasemnogene Abeparvovcec Infusion
Determining the interaction of Kisqali (600 MG Dose) and Onasemnogene Abeparvovcec Infusion and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
Generic Name: onasemnogene abeparvovec
Brand name: Zolgensma, Zolgensma
Synonyms: Onasemnogene abeparvovec (Zolgensma), Onasemnogene Abeparvovec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali (600 MG Dose)-Onasemnogene Abeparvovec
- Kisqali (600 MG Dose)-Onasemnogene abeparvovec Zolgensma
- Kisqali (600 MG Dose)-Oncaspar
- Kisqali (600 MG Dose)-Oncovin
- Kisqali (600 MG Dose)-Ondansetron
- Kisqali (600 MG Dose)-Ondansetron and Dextrose
- Onasemnogene Abeparvovcec Infusion-Kisqali Femara Co-Pack
- Onasemnogene Abeparvovcec Infusion-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Onasemnogene Abeparvovcec Infusion-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Onasemnogene Abeparvovcec Infusion-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Onasemnogene Abeparvovcec Infusion-Kitabis Pak
- Onasemnogene Abeparvovcec Infusion-Kitabis Pak inhalation